Lori J. Maness

3.6k total citations
59 papers, 569 citations indexed

About

Lori J. Maness is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Lori J. Maness has authored 59 papers receiving a total of 569 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Hematology, 21 papers in Oncology and 19 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Lori J. Maness's work include Acute Myeloid Leukemia Research (21 papers), Acute Lymphoblastic Leukemia research (17 papers) and Neutropenia and Cancer Infections (12 papers). Lori J. Maness is often cited by papers focused on Acute Myeloid Leukemia Research (21 papers), Acute Lymphoblastic Leukemia research (17 papers) and Neutropenia and Cancer Infections (12 papers). Lori J. Maness collaborates with scholars based in United States, France and Germany. Lori J. Maness's co-authors include Vijaya Raj Bhatt, Krishna Gundabolu, Jamés O. Armitage, Valerie Shostrom, Julie M. Vose, R. Gregory Bociek, Philip J. Bierman, Smith Giri, Frederick R. Appelbaum and Zaid Al‐Kadhimi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Lori J. Maness

56 papers receiving 558 citations

Peers

Lori J. Maness
Yu‐Min Shen United States
Ikhwan Rinaldi Indonesia
Jennifer E. Schwartz United States
Laura Winter United States
Jieyu Ye China
Saad Al‐Ismail United Kingdom
Yu‐Min Shen United States
Lori J. Maness
Citations per year, relative to Lori J. Maness Lori J. Maness (= 1×) peers Yu‐Min Shen

Countries citing papers authored by Lori J. Maness

Since Specialization
Citations

This map shows the geographic impact of Lori J. Maness's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lori J. Maness with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lori J. Maness more than expected).

Fields of papers citing papers by Lori J. Maness

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lori J. Maness. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lori J. Maness. The network helps show where Lori J. Maness may publish in the future.

Co-authorship network of co-authors of Lori J. Maness

This figure shows the co-authorship network connecting the top 25 collaborators of Lori J. Maness. A scholar is included among the top collaborators of Lori J. Maness based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lori J. Maness. Lori J. Maness is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deininger, Michael W., Jane Apperley, Christopher Arthur, et al.. (2024). Ponatinib (PON) in patients (pts) with chronic-phase chronic myeloid leukemia (CP-CML) and the T315I mutation (mut): 4-year results from OPTIC.. Journal of Clinical Oncology. 42(16_suppl). 6501–6501.
2.
Bhatt, Vijaya Raj, Valerie Shostrom, Hannah Choe, et al.. (2024). A Multicenter Phase II Trial of Ruxolitinib for Treatment of Corticosteroid Refractory Sclerotic Chronic Graft-Versus-Host Disease. Journal of Clinical Oncology. 42(33). 3977–3985. 6 indexed citations
4.
Bhatt, Vijaya Raj, Christopher Wichman, Thuy T. Koll, et al.. (2023). Longitudinal changes in cognitive and physical function and health-related quality of life in older adults with acute myeloid leukemia. Journal of Geriatric Oncology. 15(1). 101676–101676. 8 indexed citations
5.
Bhatt, Vijaya Raj, Valerie Shostrom, Sarah A. Holstein, et al.. (2020). Survival of Older Adults With Newly Diagnosed Acute Myeloid Leukemia: Effect of Using Multiagent Versus Single-agent Chemotherapy. Clinical Lymphoma Myeloma & Leukemia. 20(5). e239–e258. 7 indexed citations
6.
Dhakal, Prajwal, Valerie Shostrom, Zaid Al‐Kadhimi, et al.. (2020). Usefulness of Charlson Comorbidity Index to Predict Early Mortality and Overall Survival in Older Patients With Acute Myeloid Leukemia. Clinical Lymphoma Myeloma & Leukemia. 20(12). 804–812.e8. 20 indexed citations
7.
Dhakal, Prajwal, Elizabeth Lyden, Zaid Al‐Kadhimi, et al.. (2020). Effects of Distance From Academic Cancer Center on Overall Survival of Acute Myeloid Leukemia: Retrospective Analysis of Treated Patients. Clinical Lymphoma Myeloma & Leukemia. 20(10). e685–e690. 4 indexed citations
8.
Dhakal, Prajwal, Elizabeth Lyden, Joel Michalski, et al.. (2019). Effects of Obesity on Overall Survival of Adults With Acute Myeloid Leukemia. Clinical Lymphoma Myeloma & Leukemia. 20(3). e131–e136. 11 indexed citations
9.
Secrest, Aaron M., et al.. (2018). Comprehensive outreach, prevention education, and skin cancer screening for Utah ski resorts. Dermatology Online Journal. 24(2). 3 indexed citations
10.
Bhatt, Vijaya Raj, Jagar Jasem, Smith Giri, et al.. (2015). Central Nervous System Complications and Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation. Clinical Lymphoma Myeloma & Leukemia. 15(10). 606–611. 20 indexed citations
11.
Bhatt, Vijaya Raj, Fausto R. Loberiza, Hongmei Jing, et al.. (2015). Mortality Patterns Among Recipients of Autologous Hematopoietic Stem Cell Transplantation for Lymphoma and Myeloma in the Past Three Decades. Clinical Lymphoma Myeloma & Leukemia. 15(7). 409–415.e1. 18 indexed citations
12.
Khanal, Nabin, R. Gregory Bociek, Baojiang Chen, et al.. (2015). Use of Low Molecular Weight Heparin (LMWH) in Thrombocytopenic Patients with Hematologic Malignancy-Associated Venous Thromboembolism (VTE). Blood. 126(23). 3482–3482. 1 indexed citations
13.
14.
Gundabolu, Krishna, Vijaya Raj Bhatt, Lori J. Maness, et al.. (2015). Predisposition to Budd-Chiari Syndrome: A Single-Center Case Series of a Rare Subset of Venous Thromboembolism. Blood. 126(23). 4719–4719.
15.
16.
Maness, Lori J., Ipek Goktepe, & Mohamed Ahmedna. (2012). In Vitro Cancer Research on Ancient Herbal Remedies: A Changing Trend. 2 indexed citations
17.
Kantarjian, Hagop M., Stefan Faderl, Guillermo Garcia‐Manero, et al.. (2012). Oral sapacitabine for the treatment of acute myeloid leukaemia in elderly patients: a randomised phase 2 study. The Lancet Oncology. 13(11). 1096–1104. 50 indexed citations
18.
O’Donnell, Margaret, Jessica K. Altman, Frederick R. Appelbaum, et al.. (2011). Acute Myeloid Leukemia. Journal of the National Comprehensive Cancer Network. 9(3). 280–317. 53 indexed citations
19.
Garcia‐Manero, Guillermo, Selina M. Luger, Parameswaran Venugopal, et al.. (2009). A Randomized Phase 2 Study of Sapacitabine, An Oral Nucleoside Analogue, in Older Patients with Myelodysplastic Syndrome (MDS) Refractory to Hypomethylating Agents.. Blood. 114(22). 1758–1758. 3 indexed citations
20.
Maness, Lori J., Donald C. Blair, Nancy Newman, & Thomas Coyle. (1998). Elevation of Platelet Counts Associated with Indinavir Treatment in Human Immunodeficiency Virus‐Infected Patients. Clinical Infectious Diseases. 26(1). 207–208. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026